AMED HealthTech Challenge: 2025 closed call
| Provider | AMED |
|---|---|
| Deadline | September 11, 2025, noon |
| Eligibility | Qualifying Japanese institution-based research representatives; early-stage startups or academics intending to create a startup, within the programme’s disease and project exclusions. Location: Eligible institutions in Japan |
| Funding | Annual direct-cost caps: ¥3.8 million in FY2025, ¥1.9 million in FY2026 and ¥7.6 million in FY2027; later continuation subject to selection. |
AMED’s HealthTech Challenge supported early-stage infectious-disease technology projects at Japanese institutions, including startup or entrepreneurship-oriented academic work. The 2025 call closed at noon on September 11. Support was staged, with continuation into later years subject to selection.
Topics
| Apply | Application details |
|---|